Menu

Our passion is transforming the data we collect into engaging insights.

A market research panel exclusively for healthcare professionals.

Industry Expertise

Since 2003, we have conducted market research in a variety of health-related areas amassing deep expertise and proprietary norms within the pharmaceutical and healthcare industry.

Superior Sample

Fueled by our proprietary market research panel of healthcare professionals, our in-house field team consistently delivers more target respondents and larger sample sizes.

Engaging Insights

Recognized in the health and pharmaceutical market research industry for our visually intuitive and engaging story-based reports, we move the boardroom conversation from understanding to taking action.

Our Proven Process Delivers High Quality Experiences

“Appreciate the client service support: on going clear communication, in timely manner, very pleasant demeanor. Also truly appreciate the attention to detail and accuracy in the report. This is a strong advantage over other suppliers.”
Naomi – Johnson & Johnson

“Great work. The bar is pretty high now.”
Martin – HLS
“This project was one of my most complicated to date. Great job from the team.”
Julie – Pendopharm

A market research panel exclusively for healthcare professionals.

Our Proven Process Delivers High Quality Experiences

“Appreciate the client service support: on going clear communication, in timely manner, very pleasant demeanor. Also truly appreciate the attention to detail and accuracy in the report. This is a strong advantage over other suppliers.”
Naomi - Johnson & Johnson

“Great work. The bar is pretty high now.”
Martin - HLS
“This project was one of my most complicated to date. Great job from the team.”
Julie - Pendopharm

Topical Polls and Industry Trends

How the Pandemic Impacted New Pharma Product Launches

How the Pandemic Impacted New Pharma Product Launches

COVID-19 has certainly brought its challenges to all parts of our lives. We surveyed 140 US physicians (50 general practitioners (GPs) and 90 specialists to see how COVID-19 has impacted product launches. In order for product launches to be successful, treaters need to learn about the products in a timely manner and be convinced of the value they bring to them.

Roughly one-third of physicians (similar proportions of GPs and specialists) said they have initiated fewer patients on newly launched products during the pandemic. The reasons cited for this decrease include: fewer interactions with pharma, reduced patient volumes, and patient reluctance.

read more
Discover How Physicians Want to Learn About New Treatments

Discover How Physicians Want to Learn About New Treatments

Engaging prescribers is a key component to the launch of any new brand. But what are the key components that drive interest for physicians in learning more?

Overall, physicians express greater satisfaction when learning about new products through in person interactions compared to virtual or digital interactions. However, regardless of how they learn about new product, the types of resources physicians prefer are similar. The top most preferred resources for both GPs and Specialists include presentation at conferences, discussions with peers, educational events that include KOLs or treatment areas experts, presentations by lead authors, journal clubs and discussions with Pharmaceutical reps. While a majority agree (66%) they are more likely to engage with reps or MSLs to discuss new products or indications, more physicians agree (87%) they are more likely to meet with a rep or MSL with whom they have an established relationship.

read more
Understanding the Impact of COVID-19 on New Pharma Product Launches

Understanding the Impact of COVID-19 on New Pharma Product Launches

The COVID-19 pandemic had a significant impact on physicians, including how they learn about and integrate new products into their practice. While not all saw a decline, close to 1 in 3 Specialists and close to half of GPs say their use of newly launched products declined during the pandemic, primarily due to a lack of pharma presence, reduced patient volumes overall and just a general lack of comfort using new products.

read more

Your answers,
our guarantee.

Your answers,
our guarantee.

Join Panel